Australia markets closed

LENZ Therapeutics, Inc. (LENZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.72+0.06 (+0.34%)
As of 09:44AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-69,968
-10,811
-7,563
Depreciation & amortisation
15
8
2
Stock-based compensation
1,343
721
196
Change in working capital
9,410
6,012
1,152
Accounts payable
856
4,295
382
Other working capital
-60,410
-4,128
-5,403
Net cash provided by operating activities
-60,380
-4,091
-5,394
Cash flows from investing activities
Investments in property, plant and equipment
-30
-37
-9
Purchases of investments
-52,091
-
-
Sales/maturities of investments
22,500
-
-
Net cash used for investing activities
-29,621
-37
-9
Cash flows from financing activities
Other financing activities
-2,479
-
-
Net cash used provided by (used for) financing activities
80,700
30,262
22,765
Net change in cash
-9,301
26,134
17,362
Cash at beginning of period
44,441
18,307
945
Cash at end of period
35,140
44,441
18,307
Free cash flow
Operating cash flow
-60,380
-4,091
-5,394
Capital expenditure
-30
-37
-9
Free cash flow
-60,410
-4,128
-5,403